Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04870762 · ClinicalTrials.gov registry record · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
A Phase 2 study of Head and Neck Carcinoma and Oral Cavity Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 119
- Enrollment target
- 7
- Study locations
NCT04870762 is a Phase 2 study of Head and Neck Carcinoma and Oral Cavity Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 119 participants, below the 409-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (71% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT04870762, a Phase 2 study of Head and Neck Carcinoma and Oral Cavity Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 119 participants
- Enrollment target
- 7
- Study locations
Study Summary
This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy. Oral stents are made from the impression of patients' mouth and cover patients' teeth and gums during radiation therapy. A customized, 3D-printed oral stent may help to reduce mouth blisters and/or sores that may develop in patients while receiving head and neck radiation therapy.
Conditions Studied
Interventions
- OTHER Medical Device Usage and Evaluation
- OTHER Best Practice
Study Locations (7)
Indiana
- Community MD Anderson Cancer Center East - Indianapolis
- Community MD Anderson Cancer Center South - Indianapolis
- Community MD Anderson Cancer Center North - Indianapolis
Arizona
- Banner Health/Banner Research - Phoenix
Florida
- Baptist MD Anderson Cancer Center - Jacksonville
New Jersey
- Cooper Hospital University Medical Center - Camden
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2021-05-26 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04870762
The ClinicalTrials.gov registry entry for NCT04870762 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 409-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (71% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Medical Device Usage and Evaluation is the first listed.
NCT04870762 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Indiana, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT04870762 about?
NCT04870762 is a clinical study titled "Customized 3D Printed Oral Stents During Head and Neck Radiotherapy". This clinical trial studies the effect of customized 3 dimensional (3D) printed oral tents on patients with head and neck cancer who are receiving radiotherapy. Oral stents are made from the impression of patients' mouth and cover patients' teeth and gums during radiation therapy. A customized, 3D-p...
What is the current status of trial NCT04870762?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 119 participants. The study started on 2021-05-26. Estimated completion is 2026-12-31.
What conditions does trial NCT04870762 study?
This clinical trial studies the following conditions: Head and Neck Carcinoma, Oral Cavity Carcinoma, Nasal Cavity Carcinoma, Maxillary Sinus Carcinoma, Tongue Carcinoma.
What interventions are being tested in trial NCT04870762?
The interventions under investigation include: Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER).
Who is sponsoring clinical trial NCT04870762?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04870762 being conducted?
This trial has 7 study locations across Arizona, Florida, Indiana, New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
RECRUITING · Phase 2
-
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
RECRUITING · Phase 2
-
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
RECRUITING · Phase 2
-
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
ACTIVE NOT RECRUITING · Phase 2
-
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
COMPLETED · Phase 2
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.